Oripavine and lisdexamfetamine; adds to list of Schedule II drugs. (HB823)

Introduced By

Del. Harvey Morgan (R-Gloucester)

Progress

Introduced
Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law

Description

Schedule II drugs; oripavine and lisdexamfetamine. Adds oripavine and lisdexamfetamine to the list of Schedule II drugs. Read the Bill »

Outcome

Bill Has Passed

History

DateAction
01/08/2008Committee
01/08/2008Prefiled and ordered printed; offered 01/09/08 084004802
01/08/2008Referred to Committee on Health, Welfare and Institutions
01/10/2008Impact statement from VCSC (HB823)
01/15/2008Reported from Health, Welfare and Institutions (22-Y 0-N) (see vote tally)
01/16/2008Read first time
01/17/2008Read second time and engrossed
01/18/2008Read third time and passed House BLOCK VOTE (98-Y 0-N)
01/18/2008VOTE: BLOCK VOTE PASSAGE (98-Y 0-N) (see vote tally)
01/18/2008Communicated to Senate
01/21/2008Constitutional reading dispensed
01/21/2008Referred to Committee on Education and Health
02/14/2008Reported from Education and Health (15-Y 0-N)
02/15/2008Constitutional reading dispensed (38-Y 1-N)
02/18/2008Read third time
02/18/2008Passed Senate (40-Y 0-N)
02/19/2008Enrolled
02/19/2008Bill text as passed House and Senate (HB823ER)
02/19/2008Impact statement from VCSC (HB823ER)
02/20/2008Impact statement from DPB (HB823ER)
02/20/2008Signed by Speaker
02/22/2008Signed by President
03/02/2008G Approved by Governor-Chapter 73 (effective 7/1/08)
03/02/2008G Approved by Governor-Chapter 74 (effective 7/1/08)
03/04/2008G Acts of Assembly Chapter text (CHAP0074)